Predictive value indicating positive test in a screening modality is calculated by:
Wait, the question is about which formula or calculation is used. Let's make sure. The options weren't provided, but the correct answer is supposed to be PPV. So the core concept here is understanding the difference between sensitivity, specificity, PPV, and NPV.
Sensitivity is true positives over all actual diseased (true positives + false negatives). Specificity is true negatives over all non-diseased (true negatives + false positives). But PPV is different because it's about the predictive value after the test is done. So PPV = true positives / (true positives + false positives). This is different from likelihood ratios or other measures.
Now, the user's options might have included other measures like sensitivity or specificity, which are about the test's ability to detect disease or rule it out, not the predictive value. Also, maybe options confused PPV with NPV. NPV is true negatives over (true negatives + false negatives).
The clinical pearl here is to remember that PPV depends on the prevalence of the disease in the population. If a disease is rare, even a positive test might have a low PPV because there could be many false positives. That's why screening in low-prevalence populations can be tricky.
So putting it all together: the correct answer is PPV, calculated as true positives divided by all positive tests. The other options might be other metrics that are frequently mixed up in exams. The key takeaway is understanding how prevalence affects predictive values, which is a high-yield point for exams like NEET or USMLE.
**Core Concept**
Positive predictive value (PPV) quantifies the probability that a patient with a positive screening test truly has the disease. It is calculated as **true positives / (true positives + false positives)** and is influenced by disease prevalence and test specificity.
**Why the Correct Answer is Right**
PPV is derived from the formula: **PPV = [True Positives] / [True Positives + False Positives]**. This reflects how many of the test-positive individuals are correctly identified as diseased. Unlike sensitivity or specificity, PPV depends on the prevalence of the disease in the population being tested. For example, in a low-prevalence setting, even a highly specific test may have a low PPV due to a high number of false positives.
**Why Each Wrong Option is Incorrect**
**Option A:** *Sensitivity* measures the proportion of actual diseased individuals correctly identified by the test (true positives / [true positives + false negatives]). It does not relate to predictive value.
**Option B:** *Specificity* measures the proportion of non-diseased individuals correctly identified as negative (true negatives / [true negatives + false positives]). It affects PPV indirectly but is not the calculation itself.
**Option C:** *Likelihood ratio* combines sensitivity and specificity to assess how much a test result shifts the probability of disease but does not directly calculate